AKTIS ONCOLOGY INC (AKTS) Institutional Ownership and Insiders Activity

AKTIS ONCOLOGY INC (AKTS) is widely held by institutional investors, with 112 firms reporting positions valued at approximately $1.08B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Mpm Bioimpact Llc is the largest disclosed holder, reporting approximately $155.86M in AKTS holdings in its latest filing.

Recent insider activity includes 28 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.